chartexchange

Immunic to Host Virtual Progressive Multiple Sclerosis R&D Day on November 5, 2026

PR Newswire | Oct 29, 2026 6:30 AM EDT

NEW YORK, Oct. 29, 2026 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic diseases, today announced that it will host a virtual Research and Development (R&D) Day focused on progressive...

Read original article